Skip to content, navigation or search.


2009 May

An astonishing example of glaring anti-supplement bias in a clinical study

A team of U.S. and German researchers tested the effect of large doses of vitamins C and E (or placebo) in nearly 40 young men who took part in a rigorous four-week exercise regimen.

Read more...

Could it now be easier than ever to get a new drug approved by the FDA?

A recent Reuters Health report notes the FDA approval of Fanapt, a powerful atypical antipsychotic drug that treats schizophrenia.

Read more...

Testosterone gel gets an urgent new safety warning

The FDA informed testosterone gel makers that they’re now required to include a black box warning with the packaging of their medications

Read more...

Statin drugs may impact PSA levels – even in men with prostate cancer

A new study reveals yet another reason to steadfastly avoid Lipitor, Zocor, Crestor and all the rest of the dangerous brand names in this drug class.

Read more...

Sugar Free aspirin? How’s that again?

It’s a come-on aimed at diabetic customers whom Bayer execs apparently presume are so hypnotized by the words “Sugar Free” that they’ll purchase any product with those words on the packaging.

Read more...


Health Disclaimer! The information provided on this site should not be construed as personal medical advice or instruction. No action should be taken based solely on the contents of this site. Readers should consult appropriate health professionals on any matter relating to their health and well-being. The information and opinions provided here are believed to be accurate and sound, based on the best judgment available to the authors, but readers who fail to consult appropriate health authorities assume the risk of any injuries. The publisher is not responsible for errors or omissions.